1992
DOI: 10.1152/ajpendo.1992.263.1.e50
|View full text |Cite
|
Sign up to set email alerts
|

Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation

Abstract: The potent anabolic effects of the beta 2-adrenoceptor agonist clenbuterol on skeletal muscle have been reported to be independent of actions on beta-adrenoceptors. In the present study clenbuterol, presented to rats in the diet (4 mg/kg), caused significant increases in gastrocnemius muscle mass, protein, and RNA content and a decrease in epididymal fat pad mass. These effects were not mimicked by oral administration of the beta 2-adrenoceptor agonist salbutamol even at high dose (52 mg/kg diet), and the effe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

9
122
1
3

Year Published

1997
1997
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 110 publications
(135 citation statements)
references
References 3 publications
9
122
1
3
Order By: Relevance
“…It is also used to treat mild-to-moderate stress incontinence (Noguchi et al, 1997) and allergic inflammation (Yoshimura et al, 1997). However, clenbuterol is also abused by individuals that practice body building because of β2 agonists' anabolic effects and reduction of subcutaneous fat (Choo et al, 1992;Hesketh et al, 1992;Navegantes et al, 2001;Prather et al, 1995;Ryall et al, 2004;Yimlamai et al, 2005). Thus, clenbuterol would seem like an attractive option for preventing muscle frailty in the elderly as has been suggested from a study in rats (Ryall et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…It is also used to treat mild-to-moderate stress incontinence (Noguchi et al, 1997) and allergic inflammation (Yoshimura et al, 1997). However, clenbuterol is also abused by individuals that practice body building because of β2 agonists' anabolic effects and reduction of subcutaneous fat (Choo et al, 1992;Hesketh et al, 1992;Navegantes et al, 2001;Prather et al, 1995;Ryall et al, 2004;Yimlamai et al, 2005). Thus, clenbuterol would seem like an attractive option for preventing muscle frailty in the elderly as has been suggested from a study in rats (Ryall et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…Its longer duration of action yields a prolonged high serum level as compared to other β 2 -agonists: this makes clenbuterol a desired agent for body-building [4,5]. Clenbuterol increases the rate of muscle protein deposition leading to enlargement of individual muscle fibers [2,5,6].…”
Section: Discussionmentioning
confidence: 99%
“…Clenbuterol increases the rate of muscle protein deposition leading to enlargement of individual muscle fibers [2,5,6]. In addition, clenbuterol promotes lipolysis in humans and animals through adipocyte β 3 -adrenoreceptors, encouraging the body to burn fatty acids [4][5][6]. Therefore, weight gain is a result of muscle hypertrophy and not fat accumulation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, epinephrine infusion caused a reduction of most plasma amino acids in normal and diabetic humans (Shamoon et al 1980) which was reversed by propranolol, thus suggesting an effect of the β-adrenoceptor system in protein and amino acid metabolism. β-adrenoceptor processes mediate protein accretion in animals (Choo et al 1992). Simulation by β-adrenergic agonists results in increased thermogenesis and protein accretion in ruminants (MacRae et al 1988).…”
mentioning
confidence: 99%